Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-12-03
2000-06-13
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142262, 514288, 514323, 514415, 514419, 514619, 514648, A01N 4342, A61K 3144
Patent
active
060750200
ABSTRACT:
Disclosed herein is a method of treating an immune system dysfunction in a mammal by administering a prolactin reducer and a prolactin enhancer at a predetermined time or times.
REFERENCES:
patent: 4310535 (1982-01-01), Pierpaoli
patent: 4665086 (1987-05-01), Short et al.
patent: 5028591 (1991-07-01), Edwards et al.
patent: 5145837 (1992-09-01), Feyen et al.
patent: 5344832 (1994-09-01), Cincotta et al.
patent: 5519047 (1996-05-01), Shelby et al.
patent: 5696128 (1997-12-01), Cincotta et al.
patent: 5872127 (1999-02-01), Cincotta et al.
Barnett et al., Postgraduate Med. J., 56:11-14, 1980.
Berczi, I. et al., Acta Endocrinologica, 98:506-513, 1980.
Berczi, I., Dev. Comp. Immunol., 13:329-341, 1989.
Bernton, E.S. et al., Science, 239:401-4, 1989.
Besedovsky, H.O. et al., J. Immunol., 135:750s-4s, 1985.
Blalock, J.E., Physiol. Rev., 69:1-32, 1989.
Blizhakov, J. Med., N.Y., 1980, 11(2/3): 81-105.
Folomeev et al., Biological Abstracts, vol. 90, abstract No. 75731, Ter Arkh, 62:62-63, 1990.
Gala, R.R., Proc. Soc. Exp. Biol. Med. 198:513-27, 1991.
Gutierrez, M.A., Rev. Rhum. Fr. Ed., 1994, 61:278-85.
Hedner et al., Am. J. Ophthalmology, Oct. 1985, 618-19.
Holaday, J.W., "Neuroendocrine--Immune Interaction", 1991, 69 (Suppl. XXVI): 13-19.
Jara et al., Ame. J. of the Med. Sci., 303:222-226, Apr. 1992.
Jara et al., Semin. Arthritis Rheum., 5:273-284, 1991.
Kukhtevich et al., The Genuine Article, abstract No. FX734, Terapevtichdkii Ardhiv, 63:99-101, 1991.
Lissoni et al., Eur. J. Cancer, 30:167-170, 1994.
Lissoni et al., Oncology, 51:344-347, 1980.
Lissoni et al., Oncology, 52:163-166, 1995.
Lopez-Korpovitch et al., AJRI, 1994, 31:32-39.
Mattsson et al., Clin. Exp. Immunol., 85:41-47., 1991.
McMurray, R., et al., J. Immunol. 147:3780-7, 1991.
Meier et al., Experientia 48, 148-153, 1992.
Neri et al., Cancer, 73:3015-3019, 1994.
Nicoletti, I. et al., J. Reprod. Immunol., 15:113-121, 1989.
Parraquez et al., J. Dev. Physiol. (1991) 16(2): 57-62.
Reder, A.T. and Lowy, M.T., J. Neurobiological Sci., 117:192-196, 1992.
Reber, P.M., Am J. Med., 1993 95 (6): 637-644.
Regelson et al., Cancer Investigation, 5:379-385, 1987.
Reichlin, S., NEJM 329:1246-53, 1993.
Rovensky, J. et al., Int. J. Immunopharmac., 13:267-272, 1991.
Vidaller, A. et al., Clin. Immunol. Immunopathol, 38:337-43, 1986.
Vidaller, A. et al., J. Clin. Immunol., 12:210-5, 1992.
Dijkstra et al., Trends Pharmacol. Sci., 14:124-129, 1993.
Cincotta Anthony H.
Meier Albert H.
Keys Rosalynd
Richter Johann
The Board of Supervisors of Louisiana State University and Agric
The General Hopital Corporation
LandOfFree
Method of regulating immune function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of regulating immune function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of regulating immune function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2068891